LOS ANGELES CAPITAL MANAGEMENT LLC - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$248,000
-19.5%
51,453
+20.7%
0.00%0.0%
Q3 2021$308,000
-28.0%
42,633
-8.0%
0.00%
-50.0%
Q2 2021$428,000
+27.0%
46,363
+69.2%
0.00%0.0%
Q1 2021$337,000
+22.5%
27,400
+40.4%
0.00%
+100.0%
Q4 2020$275,00019,5100.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders